B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
- 31 July 2005
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 29 (7), 829-839
- https://doi.org/10.1016/j.leukres.2005.01.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Predicting Progression — ZAP-70 in CLLNew England Journal of Medicine, 2004
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Chronic lymphocytic leukemiaCurrent Opinion in Hematology, 1997
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Two tumour necrosis factor receptors: structure and functionTrends in Cell Biology, 1995
- Sequential Interactions of the TCR with Two Distinct Cytoplasmic Tyrosine KinasesScience, 1994
- Serum levels of tumour necrosis factor-α in patients with B-cell chronic lymphocytic leukaemiaEuropean Journal Of Cancer, 1994
- Heterogeneous proliferative effect of tumor necrosis factor-α and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemiaAmerican Journal of Hematology, 1993
- Secretory products of macrophages.JCI Insight, 1987
- A clinical staging system for chronic lymphocytic leukemia.Prognostic significanceCancer, 1977